Breaking News on Contract Research, Manufacturing & Clinical Trials

Q&A with CEO and CMO

Medical marijuana chewing gum to treat IBS in Dutch trial

18-Jan-2017 - AXIM Biotechnologies, Inc. will start 40-person clinical trial in the Netherlands for a mint-flavoured medical marijuana chewing gum to treat Irritable bowel syndrome (IBS). 


Servier universal CAR-T therapy outsourced to Belgian CDMO

18-Jan-2017 - Servier has recruited CDMO MaSTherCell SA to manufacture its universal CAR-T candidate UCART19, licensed from the biotech Cellectis as an off-the-shelf cell therapy for leukemia.


CDMO Fujifilm adopts procurement automation solution

12-Jan-2017 - FUJIFILM Diosynth Biotechnologies USA (FDBU) has selected SciQuest to automate ‘critical’ purchasing and accounts payable processes.

Aerie to build manufacturing facility in Ireland

11-Jan-2017 - Aerie Pharmaceuticals Inc will lease a 30,000 sq ft manufacturing facility in Ireland to commercialise its eye-drop product for Glaucoma after delays at a third party CMO.

Catalent to assess resveratrol formulation across softgel platforms

11-Jan-2017 - Catalent will assess Jupiter Orphan Therapeutics’ resveratrol across its softgel technologies in an effort to improve the bioavailability of the rare disease candidate.

AGC boasts 44,000L of biomanufacturing capacity on back of recent M&A

11-Jan-2017 - After buying two CMOs, Japanese glassmaker AGC has made “a full-fledged launch” into the biologics manufacturing space and says it will consider further M&A opportunities.

Strategic partnership forms single-source solution for biopharma

10-Jan-2017 - CSSi LifeSciences and BioMARC have announced a strategic partnership to provide 'fully cohesive product development and support' for vaccine and biologic development. 

What can CROs and CMOs expect in 2017?

10-Jan-2017 - From a new administration under president-elect Donald Trump, to continued consolidation, the CRO and CMO industry can expect accelerated change – good or bad – says PCI Synthesis.

Orchard picks PharmaCell to make its autologous cell therapies

09-Jan-2017 - Orchard Therapeutics has selected Dutch CMO PharmaCell to manufacture products from its gene therapy pipeline.

Out with the old, in with the new? Lonza sells peptide biz, Recipharm adds Indian ops

05-Jan-2017 - Recipharm receives approval to buy Kemwell’s Indian operations and PolyPeptides completes the acquisition of Lonza’s peptide business. Welcome to in-Pharmatechnologist’s 2017 M&A round-up.

Catalent’s CHO cell lines and Gate’s Foundation to make PATH Malaria vaccine

21-Dec-2016 - Catalent has partnered with US non-profit PATH for antibody discovery using the CDMO’s GPEx cell line platform, funded by PATH’s Malaria Vaccine Initiative (MVI).

AGC expanding CDMO biz through $500m CMC Biologics buy

21-Dec-2016 - AGC Asahi Glass has signed an agreement to buy CMC Biologics, the second biologics CDMO acquisition for the Japanese chemicals firm in three months.

apceth Biopharma joins Lonza as bluebird bio cell therapy contractor

15-Dec-2016 - bluebird bio Inc has hired apceth Biopharma GmbH to make its candidate ALD cell therapy Lenti-D and its thalassemia treatment LentiGlobin for the European market.

PPD increases capacity, capabilities at Wisconsin-based GMP lab

14-Dec-2016 - PPD has expanded its stability sample storage capacity and capabilities at its Middleton, Wisconsin-based good manufacturing practices (GMP) lab.


Syngene's Bengaluru site damaged by fire

13-Dec-2016 - A fire has damaged a facility operated by Indian contractor, Syngene International. 

News in brief

CMO Evonik acquires silica business for $630m

13-Dec-2016 - Evonik Industries AG has acquired the silica business from the US company J.M. Huber, expanding the company’s presence in North America and Asia.

Avid on track for third plant and to clear $73m biomanufacturing backlog

13-Dec-2016 - Avid Bioservices has reported strong contract manufacturing revenues for its Q2 and is confident a planned third facility will not leave the firm with too much capacity.

Lonza confirms interest in Capsugel takeover

12-Dec-2016 - Lonza has confirmed it is interested in buying Capsugel. 

Growth in biologics and vaccines leading injectables business, Aptar Pharma

12-Dec-2016 - Aptar Pharma is nearing completion of its US-based manufacturing site, as it continues to expand globally to keep pace with growth in the injectable drug delivery industry.

Catalent joins industry group supply chain initiative

12-Dec-2016 - Catalent has become the first CDMO to join the PSCI – a voluntary industry initiative focused on the social, environmental and economic impact of the supply chain.

News in brief

Fareva opens aerosol plant as part of $40m drug and OTC business investment

08-Dec-2016 - Fareva Group has set up an aerosol manufacturing facility at its site in Richmond, Virginia as part of a $40m (€37m) investment in its drug, OTC medicine and beauty care...

Lonza to sell therapeutic peptides business to PolyPeptide

07-Dec-2016 - Lonza has agreed to sell its therapeutic peptide business to PolyPeptide Laboratories in a deal that will also see the latter firm take on 280 staff.

French connection: Vaccine biomanufacturing service providers Accinov and Biodextris merge

05-Dec-2016 - Accinov has teamed up with Canadian clinical research organisation (CRO) Biodextris to provide a transatlantic biomanufacturing ‘plug and play’ service for biopharmaceuticals—with a particular expertise in vaccines.

Spain's Idifarma adds capsule filling to service offerings

01-Dec-2016 - Idifarma has invested over €300,000 in its facility in Spain in order to offer its customers automated capsule filling for commercial batches.

Vetter data processing center completes certification

30-Nov-2016 - Vetter's new data processing center at its headquarters in Ravensburg, Germany has met all criteria required to meet the European DIN EN 50600 standard.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...